Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.02

-0.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (5753)	2/26/2002 10:57:30 PM
From: Jibacoa	of 52153

<<today the biotechs were great.>> Yes, the Biotechs did better than the market,but nothing too exciting.<g> ( I saw some livelier % gainers on other market sectors.<g>) Except for GNSC (up 10.94%) and IMNR (up 13.48%) there weren't any other double digits % gainers.<g> Albeit MEDX (up 9.89%) SCIO (up 9.40%) and VICL (up 9.15%) were somewhat close.<g> PHAR (up 11.27%) is not really a Biotech. The shares were up on low volume (14K) in spite of the report today of a wider loss and having received the last $500K payment from AZN. The gain was probably related to expectations of FDA clearance to market the ENOX test that they have developed with AVE to check anticoagulation with LOVENOX. The ELECT trial is supposed to be completed by mid-May and they expect to do 2.5 million tests per year, after FDA's approval.<g> RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next